Companies · Healthtech

Diana Health, Inc.

New York · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Diana Health, Inc. — recommendation, valuation, rhythm, risks.
$66.0M
Total raised · real
2
Rounds
5.2×
Latest step-up
Top 8%
Sector rank · raised
Series C
Latest stage · inferred · Thu Aug 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Diana Health, Inc. looks fair against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 1.04× the median modeled value of Series C Healthtech companies in 2025–2027 (19 peers) — value vs value, same stage and era.
  • Within the normal band (104% of peer median) for its niche.
Active
  • Last raise 11 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Diana Health, Inc. is one of 2138 Healthtech companies tracked from New York. By capital raised it ranks among the largest (ahead of 93% of sector peers), and among the largest by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
7
Investors (latest)
2025-08-14
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$125M$250M$375M$500MSeries A · 2021-09-22 Raised $11M (real) Modeled valuation $152M (est)$11M$152MSeries A2021Series C · 2025-08-14 Raised $55M (real) Modeled valuation $345M (est)$55M$345MSeries C2025+$55MCumulative $66M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$10.7M · 2021
Series C$55.4M · 2025no Series B on file

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series B — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 40%.

Modeled valuation trajectory
$344.9M
Base estimate est.
$201.3M
Conservative case
$449.1M
Upside case
$369.2M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ca $40M–$100M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $151.6M · 2021-09-222021Series C · modeled $344.9M · 2025-08-142025
Model inputs · modeled:benchmark-stage-stepup-v1
15%
Dilution assumption
Implied ownership sold in the financing.
73%
Survival probability
55% low · 85% high
1.32×/yr
Annual markup
1.51×/yr upside case
0.9 yr
Elapsed time used
0.9 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
47 mo
Avg between rounds
$17.0M/yr
Capital velocity
4.8 yr
On record since
2021
First round
2
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 15× above median
This company$66.0M
Sector median$4.5M
Latest round — vs other Series C rounds in sector (real $, this stage) 1.2× above median
This company$55.4M
Sector median$46.5M
Modeled value — vs sector median (estimate, all stages) 10× above median
This company$344.9M
Sector median$33.8M

Raised more than 93% of sector peers (real $). Modeled value above 91% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series C) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #8 of 19.

This companyCohort peer
$100.0M$1.0B$10.0M$100.0M$1.0BCapital raised (log)Thyme Care, Inc. · Series C Raised $214.3M · modeled $667.8M (est)Cohere Health Inc. · Series C Raised $166.1M · modeled $604.1M (est)All Inspire Health, Inc. · Series C Raised $137.4M · modeled $549.8M (est)Harbor Health Team Inc. · Series C Raised $189.1M · modeled $516.2M (est)Apreo Health, Inc. · Series C Raised $81.8M · modeled $512.9M (est)4C Medical Technologies, Inc. · Series C Raised $145.5M · modeled $382.9M (est)Sprinter Health, Inc. · Series C Raised $55.0M · modeled $378.5M (est)Equip Health, Inc. · Series C Raised $163.8M · modeled $343.2M (est)Ascend Wellness Holdings, Inc. · Series C Raised $219.1M · modeled $330.6M (est)XO Health Inc. · Series C Raised $52.2M · modeled $323.4M (est)Health Catalyst, Inc. · Series C Raised $414.2M · modeled $323.3M (est)Diana Health, Inc. (this company) Raised $66.0M · modeled $344.9M (est)Diana Health, Inc.
CompanyStageRaised · realValue · estvs peer med.
Thyme Care, Inc.Series C$214.3M$667.8M2.02×
Cohere Health Inc.Series C$166.1M$604.1M1.83×
All Inspire Health, Inc.Series C$137.4M$549.8M1.66×
Harbor Health Team Inc.Series C$189.1M$516.2M1.56×
Apreo Health, Inc.Series C$81.8M$512.9M1.55×
4C Medical Technologies, Inc.Series C$145.5M$382.9M1.16×
Sprinter Health, Inc.Series C$55.0M$378.5M1.14×
Diana Health, Inc. this companySeries C$66.0M$344.9M1.04×
Equip Health, Inc.Series C$163.8M$343.2M1.04×
Ascend Wellness Holdings, Inc.Series C$219.1M$330.6M1.00×
XO Health Inc.Series C$52.2M$323.4M0.98×
Health Catalyst, Inc.Series C$414.2M$323.3M0.98×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$10.7M2021-09-22$48.5M$151.6M90%
Series C$55.4M2025-08-14$369.2M$344.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$10.7M2021-09-22
    • First recorded raise — entered as Series A.
    • 5 investors on this round.
  2. Series C$55.4M2025-08-14
    • Raised again after 47 mo — slower than the ~14 mo sector norm.
    • Round 5.2× larger than the prior — scaling up.
    • 7 investors on this round.
Intelligence
2029 ~Q3
Modeled next raise · ~47mo cadence
$166.1M
Modeled next size est.range $108.0M$265.8M
5.2×
Last step-up
$17.0M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Brenton Fargnoli6 other2021-09
Payal Divakaran2 other2025-08
Ellen Herlacher1 other2025-08
Jeffrey DeFlavio1 other2025-08
Neel Shah1 other2025-08
Payal Agrawal Divakaran1 other2021-09
Ellen Herlacker2021-09
Irem Rami2025-08
Jeff De Flavio2021-09
Kate Condliffe2021-09
Witney McKiernan2025-08
Registry & provenance

Diana Health, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1911790
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Thyme Care, Inc.HealthtechSeries C$214.3M$667.8Mnetwork1 shared operator · same sector · same stage
Accountable Care Transactions, Inc.HealthtechSeries C$65.2M$492.9Msame sector · same stage
Heartbeat Health, Inc.HealthtechSeries B$53.0M$164.6Mnetwork1 shared operator · same sector
Diverge Health, Inc.HealthtechSeries C$68.2M$407.5Msame sector · same stage
Columbia Africa Healthcare, LLCHealthtechSeries C$75.0M$579.8Msame sector · same stage
Form Health, Inc.HealthtechSeries C$76.0M$369.9Msame sector · same stage
Sprinter Health, Inc.HealthtechSeries C$55.0M$378.5Msame sector · same stage
Adagio Medical, Inc.HealthtechSeries C$81.6M$128.0Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Venus Health Science, LLCHealthtechSeed$6.3M86%
Clinicom Healthcare IncHealthtechSeries A$31.6M85%
Magnolia Medical Technologies, Inc.HealthtechSeries C$727.7M84%
Potomac Health Solutions, Inc.HealthtechPre-Seed$23.6M84%
Cortex Health, Inc.HealthtechSeed$12.5M84%
Zea Health, Inc.HealthtechSeed$7.3M84%
Wellvana Health, LLCHealthtechSeries C$154.3M84%
What About Health, Inc.HealthtechPre-Seed$7.6M84%
Frequently asked
How much funding has Diana Health, Inc. raised?
Diana Health, Inc. has raised approximately $66.0M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Diana Health, Inc.'s estimated valuation?
Provath's modeled valuation for Diana Health, Inc. is approximately $344.9M (modeled range $201.3M–$449.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Diana Health, Inc. at?
Diana Health, Inc.'s latest modeled financing stage is Series C. Its most recent recorded round closed around Thu Aug 14.
What does Diana Health, Inc. do and where is it based?
Diana Health, Inc. operates in the Healthtech sector, based in New York.
Explore related

See where Diana Health, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Diana Health, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.